nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.147	0.215	CbGbCtD
Ergonovine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0992	0.145	CbGbCtD
Ergonovine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0946	0.139	CbGbCtD
Ergonovine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0844	0.124	CbGbCtD
Ergonovine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0826	0.121	CbGbCtD
Ergonovine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.078	0.114	CbGbCtD
Ergonovine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0495	0.0726	CbGbCtD
Ergonovine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0467	0.0685	CbGbCtD
Ergonovine—Ventricular arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00826	0.0374	CcSEcCtD
Ergonovine—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.00427	0.0194	CcSEcCtD
Ergonovine—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.00427	0.0194	CcSEcCtD
Ergonovine—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.00404	0.0183	CcSEcCtD
Ergonovine—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.0177	CcSEcCtD
Ergonovine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00385	0.0175	CcSEcCtD
Ergonovine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00371	0.0168	CcSEcCtD
Ergonovine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00371	0.0168	CcSEcCtD
Ergonovine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.0036	0.0163	CcSEcCtD
Ergonovine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00354	0.016	CcSEcCtD
Ergonovine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.0035	0.0159	CcSEcCtD
Ergonovine—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00326	0.0148	CcSEcCtD
Ergonovine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00267	0.0121	CcSEcCtD
Ergonovine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00259	0.0117	CcSEcCtD
Ergonovine—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00257	0.0116	CcSEcCtD
Ergonovine—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00257	0.0116	CcSEcCtD
Ergonovine—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00255	0.0116	CcSEcCtD
Ergonovine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00255	0.0116	CcSEcCtD
Ergonovine—Methylergometrine—HTR2A—chronic obstructive pulmonary disease	0.00249	0.165	CrCbGaD
Ergonovine—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.0112	CcSEcCtD
Ergonovine—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00248	0.0112	CcSEcCtD
Ergonovine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00236	0.0107	CcSEcCtD
Ergonovine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.0107	CcSEcCtD
Ergonovine—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.0106	CcSEcCtD
Ergonovine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00228	0.0103	CcSEcCtD
Ergonovine—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00224	0.0102	CcSEcCtD
Ergonovine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00224	0.0101	CcSEcCtD
Ergonovine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00223	0.0101	CcSEcCtD
Ergonovine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00218	0.00986	CcSEcCtD
Ergonovine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00216	0.0098	CcSEcCtD
Ergonovine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00215	0.00972	CcSEcCtD
Ergonovine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.00972	CcSEcCtD
Ergonovine—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00211	0.00958	CcSEcCtD
Ergonovine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00208	0.00942	CcSEcCtD
Ergonovine—Methysergide—HTR2A—chronic obstructive pulmonary disease	0.00208	0.138	CrCbGaD
Ergonovine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00932	CcSEcCtD
Ergonovine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00205	0.00929	CcSEcCtD
Ergonovine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00204	0.00924	CcSEcCtD
Ergonovine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00917	CcSEcCtD
Ergonovine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.00886	CcSEcCtD
Ergonovine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00196	0.00886	CcSEcCtD
Ergonovine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00194	0.0088	CcSEcCtD
Ergonovine—Pergolide—HTR2A—chronic obstructive pulmonary disease	0.00192	0.128	CrCbGaD
Ergonovine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00192	0.00868	CcSEcCtD
Ergonovine—Ergotamine—CYP1A2—chronic obstructive pulmonary disease	0.0019	0.126	CrCbGaD
Ergonovine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.00837	CcSEcCtD
Ergonovine—Bromocriptine—CYP1A2—chronic obstructive pulmonary disease	0.00183	0.122	CrCbGaD
Ergonovine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.0018	0.00815	CcSEcCtD
Ergonovine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.0018	0.00815	CcSEcCtD
Ergonovine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00178	0.00808	CcSEcCtD
Ergonovine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00798	CcSEcCtD
Ergonovine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00796	CcSEcCtD
Ergonovine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00796	CcSEcCtD
Ergonovine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00785	CcSEcCtD
Ergonovine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00785	CcSEcCtD
Ergonovine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00782	CcSEcCtD
Ergonovine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00172	0.00781	CcSEcCtD
Ergonovine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00769	CcSEcCtD
Ergonovine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00762	CcSEcCtD
Ergonovine—Lisuride—HTR2A—chronic obstructive pulmonary disease	0.00167	0.111	CrCbGaD
Ergonovine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00751	CcSEcCtD
Ergonovine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00741	CcSEcCtD
Ergonovine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00739	CcSEcCtD
Ergonovine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00737	CcSEcCtD
Ergonovine—Ergotamine—HTR2A—chronic obstructive pulmonary disease	0.0016	0.107	CrCbGaD
Ergonovine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00703	CcSEcCtD
Ergonovine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00703	CcSEcCtD
Ergonovine—Bromocriptine—HTR2A—chronic obstructive pulmonary disease	0.00155	0.103	CrCbGaD
Ergonovine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00699	CcSEcCtD
Ergonovine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00696	CcSEcCtD
Ergonovine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00687	CcSEcCtD
Ergonovine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00676	CcSEcCtD
Ergonovine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00671	CcSEcCtD
Ergonovine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00671	CcSEcCtD
Ergonovine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00664	CcSEcCtD
Ergonovine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00654	CcSEcCtD
Ergonovine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00633	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.0063	CcSEcCtD
Ergonovine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.00628	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.00626	CcSEcCtD
Ergonovine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00137	0.00619	CcSEcCtD
Ergonovine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00616	CcSEcCtD
Ergonovine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00615	CcSEcCtD
Ergonovine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00615	CcSEcCtD
Ergonovine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00603	CcSEcCtD
Ergonovine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00595	CcSEcCtD
Ergonovine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00595	CcSEcCtD
Ergonovine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00593	CcSEcCtD
Ergonovine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00587	CcSEcCtD
Ergonovine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00584	CcSEcCtD
Ergonovine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00584	CcSEcCtD
Ergonovine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00582	CcSEcCtD
Ergonovine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00581	CcSEcCtD
Ergonovine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00561	CcSEcCtD
Ergonovine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00554	CcSEcCtD
Ergonovine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00515	CcSEcCtD
Ergonovine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00515	CcSEcCtD
Ergonovine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00504	CcSEcCtD
Ergonovine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00497	CcSEcCtD
Ergonovine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00497	CcSEcCtD
Ergonovine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00487	CcSEcCtD
Ergonovine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00486	CcSEcCtD
Ergonovine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00478	CcSEcCtD
Ergonovine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00478	CcSEcCtD
Ergonovine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00471	CcSEcCtD
Ergonovine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00471	CcSEcCtD
Ergonovine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.0047	CcSEcCtD
Ergonovine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00468	CcSEcCtD
Ergonovine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00462	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00458	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.001	0.00455	CcSEcCtD
Ergonovine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000997	0.00452	CcSEcCtD
Ergonovine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00099	0.00448	CcSEcCtD
Ergonovine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000986	0.00447	CcSEcCtD
Ergonovine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000986	0.00447	CcSEcCtD
Ergonovine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000982	0.00445	CcSEcCtD
Ergonovine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000969	0.0118	CbGpPWpGaD
Ergonovine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000966	0.00438	CcSEcCtD
Ergonovine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000951	0.00431	CcSEcCtD
Ergonovine—HTR2C—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000951	0.0115	CbGpPWpGaD
Ergonovine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000936	0.00424	CcSEcCtD
Ergonovine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000931	0.00422	CcSEcCtD
Ergonovine—ADRA1A—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.000924	0.0112	CbGpPWpGaD
Ergonovine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000915	0.00415	CcSEcCtD
Ergonovine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000884	0.00401	CcSEcCtD
Ergonovine—ADRA1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000869	0.0106	CbGpPWpGaD
Ergonovine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000869	0.00394	CcSEcCtD
Ergonovine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000842	0.0102	CbGpPWpGaD
Ergonovine—ADRA1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000808	0.00981	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000801	0.00973	CbGpPWpGaD
Ergonovine—HTR2C—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000799	0.0097	CbGpPWpGaD
Ergonovine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000766	0.0093	CbGpPWpGaD
Ergonovine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000747	0.00908	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000744	0.00903	CbGpPWpGaD
Ergonovine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000734	0.00891	CbGpPWpGaD
Ergonovine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000719	0.00326	CcSEcCtD
Ergonovine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000704	0.00855	CbGpPWpGaD
Ergonovine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000691	0.00313	CcSEcCtD
Ergonovine—ADRA1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000679	0.00825	CbGpPWpGaD
Ergonovine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000677	0.00822	CbGpPWpGaD
Ergonovine—ADRA1A—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	0.00067	0.00814	CbGpPWpGaD
Ergonovine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000643	0.00291	CcSEcCtD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000637	0.00773	CbGpPWpGaD
Ergonovine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000631	0.00286	CcSEcCtD
Ergonovine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000612	0.00743	CbGpPWpGaD
Ergonovine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000594	0.00269	CcSEcCtD
Ergonovine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000587	0.00713	CbGpPWpGaD
Ergonovine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000563	0.00255	CcSEcCtD
Ergonovine—ADRA1A—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.000563	0.00683	CbGpPWpGaD
Ergonovine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000557	0.00676	CbGpPWpGaD
Ergonovine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00242	CcSEcCtD
Ergonovine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000534	0.00242	CcSEcCtD
Ergonovine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000516	0.00234	CcSEcCtD
Ergonovine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000512	0.00621	CbGpPWpGaD
Ergonovine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000492	0.00597	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000485	0.00589	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000467	0.00566	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000466	0.00566	CbGpPWpGaD
Ergonovine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000461	0.00559	CbGpPWpGaD
Ergonovine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000447	0.00203	CcSEcCtD
Ergonovine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000432	0.00196	CcSEcCtD
Ergonovine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000429	0.00521	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000425	0.00517	CbGpPWpGaD
Ergonovine—ADRA1A—AMPK Signaling—LEP—chronic obstructive pulmonary disease	0.000416	0.00506	CbGpPWpGaD
Ergonovine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000415	0.00188	CcSEcCtD
Ergonovine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000409	0.00185	CcSEcCtD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.0004	0.00485	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000397	0.00482	CbGpPWpGaD
Ergonovine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000388	0.00176	CcSEcCtD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000374	0.00454	CbGpPWpGaD
Ergonovine—HTR1E—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000365	0.00443	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000362	0.00439	CbGpPWpGaD
Ergonovine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.00439	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000357	0.00434	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000341	0.00414	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00034	0.00413	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00032	0.00389	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000318	0.00386	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000313	0.0038	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000312	0.00379	CbGpPWpGaD
Ergonovine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00031	0.00376	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000309	0.00375	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000304	0.00369	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000299	0.00363	CbGpPWpGaD
Ergonovine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000292	0.00355	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000292	0.00354	CbGpPWpGaD
Ergonovine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.0035	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000279	0.00339	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000277	0.00337	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000274	0.00333	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000272	0.00331	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000272	0.0033	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000271	0.00329	CbGpPWpGaD
Ergonovine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.00319	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000258	0.00314	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000249	0.00302	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000244	0.00296	CbGpPWpGaD
Ergonovine—HTR1E—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000243	0.00295	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000243	0.00295	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000241	0.00292	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000238	0.00289	CbGpPWpGaD
Ergonovine—HTR2C—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000237	0.00288	CbGpPWpGaD
Ergonovine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00288	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000235	0.00285	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000231	0.0028	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000218	0.00264	CbGpPWpGaD
Ergonovine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.00258	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000212	0.00258	CbGpPWpGaD
Ergonovine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00255	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000208	0.00252	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000206	0.0025	CbGpPWpGaD
Ergonovine—ADRA1A—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000202	0.00245	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000201	0.00244	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.0002	0.00243	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.0002	0.00242	CbGpPWpGaD
Ergonovine—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000193	0.00234	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000183	0.00223	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000182	0.00222	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00018	0.00219	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00018	0.00218	CbGpPWpGaD
Ergonovine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00209	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000172	0.00209	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000171	0.00208	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000171	0.00208	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00017	0.00206	CbGpPWpGaD
Ergonovine—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.00017	0.00206	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.00016	0.00194	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000157	0.00191	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000156	0.0019	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000156	0.00189	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000155	0.00189	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000154	0.00187	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000153	0.00186	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000153	0.00186	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000153	0.00185	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000151	0.00184	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00015	0.00182	CbGpPWpGaD
Ergonovine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00015	0.00182	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000147	0.00179	CbGpPWpGaD
Ergonovine—HTR1E—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000147	0.00178	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000145	0.00177	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00014	0.00169	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000138	0.00167	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000137	0.00166	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000134	0.00163	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000134	0.00162	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000132	0.0016	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00013	0.00158	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.00013	0.00157	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00153	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000125	0.00152	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00151	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000122	0.00148	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000121	0.00147	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00012	0.00145	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000119	0.00145	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000119	0.00144	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000117	0.00142	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000116	0.00141	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000111	0.00135	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000108	0.00131	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000106	0.00129	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000105	0.00127	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00126	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000103	0.00125	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000102	0.00124	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.0001	0.00121	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.71e-05	0.00118	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.65e-05	0.00117	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	9.58e-05	0.00116	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.52e-05	0.00116	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.23e-05	0.00112	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.18e-05	0.00111	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.15e-05	0.00111	CbGpPWpGaD
Ergonovine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.02e-05	0.0011	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.65e-05	0.00105	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.31e-05	0.00101	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.26e-05	0.001	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.24e-05	0.001	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	8.15e-05	0.000989	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.91e-05	0.000961	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.86e-05	0.000954	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.8e-05	0.000948	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.73e-05	0.000939	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	7.7e-05	0.000935	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.54e-05	0.000916	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.49e-05	0.00091	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.4e-05	0.000898	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.39e-05	0.000898	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	7.37e-05	0.000894	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.36e-05	0.000894	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.36e-05	0.000893	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.21e-05	0.000876	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.16e-05	0.000869	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.02e-05	0.000852	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.76e-05	0.000821	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.71e-05	0.000814	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.68e-05	0.000811	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.57e-05	0.000798	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	6.4e-05	0.000777	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.29e-05	0.000764	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.29e-05	0.000763	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	6.26e-05	0.00076	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.14e-05	0.000746	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.14e-05	0.000745	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.97e-05	0.000725	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.87e-05	0.000713	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.76e-05	0.000699	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.75e-05	0.000698	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.51e-05	0.000669	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.48e-05	0.000666	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.41e-05	0.000657	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.26e-05	0.000639	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.22e-05	0.000634	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.03e-05	0.000611	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.02e-05	0.00061	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.87e-05	0.000592	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.83e-05	0.000587	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.74e-05	0.000576	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.64e-05	0.000563	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.6e-05	0.000558	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.46e-05	0.000541	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.41e-05	0.000535	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.28e-05	0.000519	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.24e-05	0.000514	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.2e-05	0.000511	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.18e-05	0.000507	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.16e-05	0.000505	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.15e-05	0.000504	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.03e-05	0.000489	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.95e-05	0.000479	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.79e-05	0.000461	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.79e-05	0.000461	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.77e-05	0.000458	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.69e-05	0.000447	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.63e-05	0.000441	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.62e-05	0.000439	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.55e-05	0.000431	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.53e-05	0.000428	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.49e-05	0.000424	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.37e-05	0.00041	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.32e-05	0.000403	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.26e-05	0.000395	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.23e-05	0.000392	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.21e-05	0.000389	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.08e-05	0.000375	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.91e-05	0.000354	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.87e-05	0.000349	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.87e-05	0.000348	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.77e-05	0.000337	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.73e-05	0.000332	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.68e-05	0.000325	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.65e-05	0.000321	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.59e-05	0.000315	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.56e-05	0.000311	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.54e-05	0.000308	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.53e-05	0.000307	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.5e-05	0.000304	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.36e-05	0.000286	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.34e-05	0.000284	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.25e-05	0.000273	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.24e-05	0.000272	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.15e-05	0.000261	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.15e-05	0.000261	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.13e-05	0.000259	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.03e-05	0.000246	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.91e-05	0.000231	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.82e-05	0.000221	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.81e-05	0.00022	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.8e-05	0.000218	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.77e-05	0.000215	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.73e-05	0.00021	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.72e-05	0.000209	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.67e-05	0.000203	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.65e-05	0.0002	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.65e-05	0.0002	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.64e-05	0.000199	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.00019	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.55e-05	0.000188	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.42e-05	0.000173	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.39e-05	0.000169	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.38e-05	0.000167	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.26e-05	0.000153	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.17e-05	0.000142	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.07e-05	0.00013	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000129	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000123	CbGpPWpGaD
